The proposed study is a pilot randomized clinical trial (RCT). Participants in the
intervention arm will participate in a 90-day adherence promotion program based on the theory
of behavioral economics and administered through the Wellth mobile phone application.
Subjects will be provided a CleverCap® Lite BLE C035 smart pill bottle (electronic monitoring
(EM), device) containing a 90-day supply of aspirin (90 pills) and those in the intervention
arm will be offered $150 for app-based medication check-ins, which consist of uploading daily
photos of pills at the time of administration through the Wellth app. Subjects will have $2
deducted from total rewards for each day that a medication check-in is missed. Subjects in
the control arm will receive usual care and be monitored with the same EM device types used
in the intervention arm.